ADMA

$0.00

(

+0.00%

)
Quote details

stock

ADMA Biologics Inc

NASDAQ | ADMA

14.95

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 14, 2025)

$3.47B

Market Cap

17.12

P/E Ratio

0.85

EPS

$25.67

52 Week High

$13.50

52 Week Low

HEALTHCARE

Sector

ADMA Chart

Recent Chart
Price Action

ADMA Technicals

Tags:

ADMA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $220M
Total Revenue $426M
Cost Of Revenue $207M
Costof Goods And Services Sold $207M
Operating Income $139M
Selling General And Administrative $74M
Research And Development $1.8M
Operating Expenses $81M
Investment Income Net -
Net Interest Income -$12M
Interest Income $2.1M
Interest Expense $14M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8M
Income Before Tax $126M
Income Tax Expense -$72M
Interest And Debt Expense -
Net Income From Continuing Operations $198M
Comprehensive Income Net Of Tax -
Ebit $140M
Ebitda $148M
Net Income $198M

Revenue & Profitability

Earnings Performance

ADMA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $489M
Total Current Assets $331M
Cash And Cash Equivalents At Carrying Value $103M
Cash And Short Term Investments $103M
Inventory $170M
Current Net Receivables $50M
Total Non Current Assets $157M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $460K
Intangible Assets Excluding Goodwill $460K
Goodwill $3.5M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $8M
Other Non Current Assets -
Total Liabilities $140M
Total Current Liabilities $56M
Current Accounts Payable $20M
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $84M
Capital Lease Obligations $9.8M
Long Term Debt $72M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $82M
Other Current Liabilities $30M
Other Non Current Liabilities $1.7M
Total Shareholder Equity $349M
Treasury Stock -
Retained Earnings -$309M
Common Stock $24K
Common Stock Shares Outstanding $243M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $119M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8M
Capital Expenditures $8.6M
Change In Receivables -
Change In Inventory $2.7M
Profit Loss -
Cashflow From Investment -$8.6M
Cashflow From Financing -$58M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $198M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $220M
Total Revenue $426M
Cost Of Revenue $207M
Costof Goods And Services Sold $207M
Operating Income $139M
Selling General And Administrative $74M
Research And Development $1.8M
Operating Expenses $81M
Investment Income Net -
Net Interest Income -$12M
Interest Income $2.1M
Interest Expense $14M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8M
Income Before Tax $126M
Income Tax Expense -$72M
Interest And Debt Expense -
Net Income From Continuing Operations $198M
Comprehensive Income Net Of Tax -
Ebit $140M
Ebitda $148M
Net Income $198M

ADMA News

ADMA Profile

ADMA Biologics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

ADMA Biologics, Inc. is a biopharmaceutical company focused on the development, manufacturing, and commercialization of plasma-derived products aimed at treating immunodeficiencies and infectious diseases in the United States. With its headquarters in Ramsey, New Jersey, ADMA leverages its proprietary production technologies to enhance patient outcomes through innovative therapies. The company is positioned within a growing market, addressing critical medical needs with a robust pipeline and a commitment to quality in its biological products.

VHAI
0.00%
$0.00
YYAI
-11.76%
$0.15
BURU
-19.92%
$0.41
UGRO
+54.52%
$0.57
BITF
+9.27%
$5.89
NVDA
-4.40%
$180.03
PLUG
+3.84%
$4.05
CGBS
-39.47%
$0.03
NVTS
+26.07%
$12.57
TMQ
+61.58%
$10.60
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+7.99%
$18.11
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.01%
$0.34
F
+0.95%
$11.65
EDHL
+114.42%
$1.07
COOT
+46.21%
$0.96
CRML
+28.73%
$29.97
DVLT
+28.82%
$2.19
NAK
+3.75%
$2.76
SOUN
+8.98%
$20.86
ACHR
+1.95%
$13.02
WULF
+10.42%
$15.46
BBD
+1.94%
$3.15
TLRY
-5.32%
$1.60
SOFI
+2.68%
$27.87
GPUS
-5.58%
$0.40
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
MNTS
+19.58%
$1.71
AXDX
-61.36%
$0.03
CLF
+0.94%
$13.96
AAL
+3.83%
$12.19
ERIC
+20.56%
$9.85
RIG
-2.50%
$3.12
ETHD
+6.60%
$3.55
UUUU
+10.34%
$26.23
CIFR
+2.70%
$20.89
NIO
-5.29%
$6.80
NUAI
+30.63%
$3.07
NEHC
+30.63%
$3.07
QUBT
+1.49%
$21.78
UAMY
+4.54%
$17.47
IREN
+8.45%
$69.56
ASST
-7.69%
$0.99
CLSK
+9.68%
$21.98
NOK
+4.19%
$5.47
GNPX
+30.15%
$0.25
BTG
+0.56%
$5.34
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
AMZN
-1.67%
$216.39
RF
+2.44%
$25.16
WWR
+35.93%
$3.48
USAR
-2.93%
$37.54
JDZG
+59.57%
$3.00
ABAT
+22.88%
$11.33
T
+2.11%
$26.13
BAC
+2.51%
$50.09
PFE
-0.84%
$24.52
QS
-0.64%
$16.88
BMNR
-6.91%
$52.92
SNAP
-1.61%
$7.92
MP
+3.77%
$98.65
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
IONQ
-5.53%
$77.55
AQMS
+198.89%
$29.62
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
WMT
+4.98%
$107.21
GWH
-16.24%
$7.58
VHAI
0.00%
$0.00
YYAI
-11.76%
$0.15
BURU
-19.92%
$0.41
UGRO
+54.52%
$0.57
BITF
+9.27%
$5.89
NVDA
-4.40%
$180.03
PLUG
+3.84%
$4.05
CGBS
-39.47%
$0.03
NVTS
+26.07%
$12.57
TMQ
+61.58%
$10.60
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+7.99%
$18.11
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.01%
$0.34
F
+0.95%
$11.65
EDHL
+114.42%
$1.07
COOT
+46.21%
$0.96
CRML
+28.73%
$29.97
DVLT
+28.82%
$2.19
NAK
+3.75%
$2.76
SOUN
+8.98%
$20.86
ACHR
+1.95%
$13.02
WULF
+10.42%
$15.46
BBD
+1.94%
$3.15
TLRY
-5.32%
$1.60
SOFI
+2.68%
$27.87
GPUS
-5.58%
$0.40
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
MNTS
+19.58%
$1.71
AXDX
-61.36%
$0.03
CLF
+0.94%
$13.96
AAL
+3.83%
$12.19
ERIC
+20.56%
$9.85
RIG
-2.50%
$3.12
ETHD
+6.60%
$3.55
UUUU
+10.34%
$26.23
CIFR
+2.70%
$20.89
NIO
-5.29%
$6.80
NUAI
+30.63%
$3.07
NEHC
+30.63%
$3.07
QUBT
+1.49%
$21.78
UAMY
+4.54%
$17.47
IREN
+8.45%
$69.56
ASST
-7.69%
$0.99
CLSK
+9.68%
$21.98
NOK
+4.19%
$5.47
GNPX
+30.15%
$0.25
BTG
+0.56%
$5.34
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
AMZN
-1.67%
$216.39
RF
+2.44%
$25.16
WWR
+35.93%
$3.48
USAR
-2.93%
$37.54
JDZG
+59.57%
$3.00
ABAT
+22.88%
$11.33
T
+2.11%
$26.13
BAC
+2.51%
$50.09
PFE
-0.84%
$24.52
QS
-0.64%
$16.88
BMNR
-6.91%
$52.92
SNAP
-1.61%
$7.92
MP
+3.77%
$98.65
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
IONQ
-5.53%
$77.55
AQMS
+198.89%
$29.62
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
WMT
+4.98%
$107.21
GWH
-16.24%
$7.58

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.